Credit Hours: CME 0.75

Target Audience:

This activity is intended for pediatricians, pulmonologists, infectious disease specialists, nurse practitioners, and nurses.

Educational Objectives:

At the conclusion of this activity, participants will be able to:

Discuss this years flu vaccine and how effective it is.
Discuss Oseltamivir and review the literature on its effectiveness against the flu virus.
Review the CDC recommendations regarding Oseltamivir usage in pediatrics.

SPECIAL NOTE:

There is no educational content to this course. This course is designed to supplement training that has already occurred. This course is designed to only administer the post-test and collect CME evaluations.

Suggested Additional Reading:

Jefferson T et al. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. (2014).

Malosh RE, Martin ET, Heikkinen T, Brooks WA, Whitley RJ, Monto AS. Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials. Clin Infect Dis. 2017 Nov 23 [Epub ahead of print]

Carmen Arriola, Shikha Garg, Evan J Anderson, Patrician A Ryan, Andrea George, Shelley M Zansky, Nancy Bennett et al; Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza, Clinical Infectious Diseases, Volume 65, Issue 8, 15 October 2017, Pages 12891297.

Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Dobson, Joanna et al. The Lancet , Volume 385 , Issue 9979 , 1729 - 1737.

Authors:

John Williams, MD — Chief of the Division of Pediatric Infectious Diseases Professor of Pediatrics at the University of Pittsburgh School of Medicine
Dr. Williams is a consultant with the Scientific Advisory Board, Quidel; and Independent Data Monitoring Committee, GSK.

Tony R. Tarchichi, MD — Assistant Professor in Pediatrics & Internal Medicine Director, Pediatric Hospital Medicine Fellowship University of Pittsburgh School of Medicine
No relationships with industry relevant to the content of this educational activity have been disclosed.

No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity.

The University of Pittsburgh is an affirmative action, equal opportunity institution.